sirolimus
Immunosuppressive medicine used to prevent rejection of transplanted organs
Facts
24 properties- Instance of
- type of chemical entity
- Subclass of
- alkaloid, (32RS)-rapamycin
- Active ingredient in
- Rapamune
- Canonical SMILES
- CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC[5]
- Chemical formula
- C₅₁H₇₉NO₁₃[6]
- Defined daily dose
- 3 mg
- Found in taxon
- Streptomyces hygroscopicus, Streptomyces iranensis, Streptomyces rapamycinicus, Purpureocillium, Ophiocordyceps[19][20][21][22][23]
- Inhibitor of
- mechanistic target of rapamycin kinase
- Isomeric SMILES
- CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O
- Legal status (medicine)
- boxed warning
- Mass
- 913.555142 Da
- Medical condition treated
- pachyonychia congenita, lymphangioleiomyomatosis, renal cell carcinoma, transplant rejection, graft-versus-host disease
- NCI Thesaurus ID
- C1212
- Physically interacts with
- FKBP prolyl isomerase 1A[4]
- Pregnancy category
- Australian pregnancy category C, US pregnancy category C
- Produced by
- Streptomyces rapamycinicus
- Route of administration
- intraperitoneal injection, oral administration, intravenous infusion and defusionههبهلخل[16][17][18]
- Significant drug interaction
- diltiazem, itraconazole, erythromycin, ritonavir, fluconazole, cyclosporine, ketoconazole[24][25][26][27][28][29][30]
- Stereoisomer of
- LSM-6188, LSM-4886
- Subject has role
- protein kinase inhibitors, antibiotic, antineoplastic antibiotics, antifungal, immunosuppressive drug, bactericide
- World Health Organisation international non-proprietary name
- sirolimus, sirólimus, sirolimusum
🏷️ Also known as
en WY-090217
en AY-22989
en (-)-rapamycin
en rapamycin
en sirolimus
ar سيروليموس
cs sirolimus
da irsolimus
de Rapamycin
en-gb sirolimus
en-gb AY-22989
en-gb WY-090217
es AY-22989
es rapamicina
es rapamisina
es sirólimus
es WY-090217
fa سیرولیموس
fi Rapamune
fi Rapamysiini
🔖 Identifiers · 48
- Library of Congress Authorities ID
- sh2001005861
- OpenAlex ID
- C2777921159
- CAS Registry Number
- 53123-88-9
- ChEBI ID
- 9168
- ChEMBL ID
- CHEMBL413
- ChemSpider ID
- 10482078
- DSSTOX compound identifier
- DTXCID503582
- DSSTox substance ID
- DTXSID5023582
- DeCS ID
- 33809
- Described at URL
- www.newscientist.com, pmc.ncbi.nlm.nih.gov, www.thelancet.com, www.medchemexpress.com
- DrugBank ID
- DB00877
Show all 48 identifiers +36
- DrugCentral ID
- 2446
- EC number
- 610-965-5
- ECHA Substance Infocard ID
- 100.107.147
- Encyclopædia Britannica Online ID
- science/rapamycin
- Freebase ID
- /m/02m01g
- Guide to Pharmacology Ligand ID
- 6031
- HSDB ID
- 7284
- InChIKey
- QFJCIRLUMZQUOT-HPLJOQBZSA-N
- J-GLOBAL ID
- 200907050996917166
- J9U entity ID
- 987007542160305171
- KEGG ID
- C07909
- KNApSAcK ID
- C00018055
- LIPID MAPS ID
- LMPK06000003
- MeSH descriptor ID
- D020123
- MeSH tree code
- D02.540.505.760
- MedlinePlus drug identifier
- a602026
- Microsoft Academic ID (discontinued)
- 2777921159
- NDF-RT ID
- N0000148624
- Natural Product Atlas ID
- NPA000414
- Nikkaji ID
- J137.896A
- PDB ligand ID
- RAP
- PatientsLikeMe treatment ID
- sirolimus
- Probes And Drugs ID
- PD003301
- PubChem CID
- 5284616
- RxNorm CUI
- 35302
- SureChEMBL ID
- 3463
- UNII
- W36ZG6FT64
- UNSPSC code
- 51201515
- UniChem compound ID
- 123924
- Wellcome Collection concept ID
- muudk6xc
- WikiProjectMed ID
- Sirolimus
- World Health Organisation international non-proprietary name numeric ID
- 7104
- Yale LUX ID
- concept/d39adf49-2a29-472d-bec6-ce4fadd58fca
🔗 Connections
Significant drug interaction 35
← Significant drug interaction 35
Medical condition treated 5
Subject has role 5
Found in taxon 3
Route of administration 3
← Drug or therapy used for treatment 3
Has use 1
Legal status (medicine) 1
Subclass of 1
← SNARC ID 1
Press Enter · cited answer in seconds